A companion magnetic sensor for in operando detection of magnetic biosynthesis in cancer and neurodegenerative models
The BioMag PoC project aims to develop a sensitive magnetic sensor for real-time monitoring of intracellular magnetic iron biosynthesis, potentially leading to novel therapies for cancer and Alzheimer's.
Projectdetails
Introduction
Iron is essential for all life forms as it is a core component of many vital metabolic processes. In humans, iron homeostasis is controlled by sophisticated processes regulating its storage, transport, and export.
Role of Iron in Diseases
More recently, the role of iron in diseases has emerged, with ferroptosis being a form of cell death that is implicated, for instance, in the onset and progression of cancer or neurodegenerative disorders.
Magnetic Iron
Here, we focus on another intriguing type of iron in the body: the magnetic iron, which seems to be involved in both homeostasis and crippling pathologies, but which goes largely unnoticed to date.
Opportunities for Therapeutic Approaches
And yet, the presence and role of such biomagnetic iron offer a significant opportunity for novel therapeutic approaches. One explanation as to why this is an unmet need most certainly stems from the lack of existing technologies that can detect the signature of biomagnetic iron in live human cells in real time.
BioMag PoC Project Solution
The solution brought by the BioMag PoC project is to make possible the in operando monitoring of intracellular biogenesis of magnetic iron in human cells, in advanced cancer and Alzheimer's models.
Proposed Technology
To do so, the project proposes a unique (ultra)sensitive magnetic sensor integrated with bioreactors to enable the real-time measurement of magnetic nanoparticles biosynthesis in the cellular environment.
Impact of the Device
The usefulness of this device goes well beyond the scope of our main ERC research, as it can have a significant impact on:
- Identifying novel therapeutic approaches to diseases by detecting iron-based new druggable targets.
- Addressing key questions related to iron metabolism towards novel diagnostics.
- Proposing a novel type of biogenic nanomedicines.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-10-2022 |
Einddatum | 31-3-2024 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Valorising magnetometry in cellsThis project aims to commercialize diamond magnetometry for measuring free radical generation in living cells, potentially leading to a startup focused on innovative diagnostic solutions. | ERC Proof of... | € 150.000 | 2022 | Details |
Signal-enhanced MRI contrast agents for neurodegenerationThis project aims to develop and validate new magnetic resonance technologies for early, non-invasive diagnosis of neurodegenerative diseases using metabolic contrast agents. | ERC Proof of... | € 150.000 | 2022 | Details |
Tailored Bacterial Magnetic Nanoparticles For Biomedical ImagingThis project aims to revolutionize biomedical applications by developing high-quality, biocompatible magnetic iron oxide nanoparticles using genetically engineered microbes for enhanced functionality and sustainability. | ERC Proof of... | € 150.000 | 2023 | Details |
MagMech: Precision magnetic tweezers for the mechanobiology of cells and tissues.The MagMech PoC project aims to enhance a novel magnetic tweezer system for applying and measuring forces in cells and tissues, facilitating advancements in mechanobiology and commercialization. | ERC Proof of... | € 150.000 | 2022 | Details |
Multifaceted molecular MRI toolbox to uncover Zn2+ in physiology and pathologyZincMRI aims to spatially map dynamic Zn2+ levels and gene expression in vivo using a novel MRI approach, enhancing our understanding of Zn2+ biology in health and disease. | ERC Consolid... | € 1.999.549 | 2023 | Details |
Valorising magnetometry in cells
This project aims to commercialize diamond magnetometry for measuring free radical generation in living cells, potentially leading to a startup focused on innovative diagnostic solutions.
Signal-enhanced MRI contrast agents for neurodegeneration
This project aims to develop and validate new magnetic resonance technologies for early, non-invasive diagnosis of neurodegenerative diseases using metabolic contrast agents.
Tailored Bacterial Magnetic Nanoparticles For Biomedical Imaging
This project aims to revolutionize biomedical applications by developing high-quality, biocompatible magnetic iron oxide nanoparticles using genetically engineered microbes for enhanced functionality and sustainability.
MagMech: Precision magnetic tweezers for the mechanobiology of cells and tissues.
The MagMech PoC project aims to enhance a novel magnetic tweezer system for applying and measuring forces in cells and tissues, facilitating advancements in mechanobiology and commercialization.
Multifaceted molecular MRI toolbox to uncover Zn2+ in physiology and pathology
ZincMRI aims to spatially map dynamic Zn2+ levels and gene expression in vivo using a novel MRI approach, enhancing our understanding of Zn2+ biology in health and disease.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulationMETA-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders. | EIC Pathfinder | € 2.987.655 | 2024 | Details |
A synaptic mechanogenetic technology to repair brain connectivityDeveloping a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy. | EIC Pathfinder | € 3.543.967 | 2023 | Details |
MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulation
META-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders.
A synaptic mechanogenetic technology to repair brain connectivity
Developing a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy.